
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145731410.1021/acsomega.7b01542ArticleAtom-Economical and Metal-Free Synthesis of Multisubstituted
Furans from Intramolecular Aziridine Ring Opening Yadav Nagendra
Nath †Jeong Hyeonsu ‡Ha Hyun-Joon *‡† Department
of Chemistry, North Eastern Regional Institute
of Science and Technology, Nirjuli, Arunachal Pradesh 791109, India‡ Department
of Chemistry, Hankuk University of Foreign
Studies, Yongin 17035, Korea* E-mail: hjha@hufs.ac.kr.01 11 2017 30 11 2017 2 11 7525 7531 13 10 2017 24 10 2017 Copyright © 2017 American Chemical Society2017American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

Multisubstituted
furans were prepared from dialkyl 2-(aziridin-2-ylmethylene)malonate
and/or 1,3-dione through aziridine ring opening by the internal carbonyl
oxygen with the assistance of BF3·OEt2,
followed by aromatization. This synthetic method is free from any
metal and is atom-economical with all of the atoms in the starting
material retained in the final product.

document-id-old-9ao7b01542document-id-new-14ao-2017-01542accc-price
==== Body
Introduction
Furans as oxygen-containing
five-membered heterocycles are an important
class of biologically active compounds.1,2 They are found
in nature and in various pharmaceuticals as well as in flavor and
fragrance.3 Synthesis of multisubstituted
furans is important not only because of their presence in various
biologically active compounds but also because they may serve as key
synthetic precursors.4 Especially, 2-aminomethylfurans
are found in many important drugs and natural products (Figure 1).2 2-Amino-methylated furans are well accessible from readily available
furan building blocks such as furfural via reductive amination reaction,
but the synthesis of substituted 2-aminomethylfurans requires multiple
steps.1a,2g−2i

Figure 1 Drugs and natural products
containing the 2-aminomethylfuran motif.

Owing to their importance, ample examples are reported in
the literature
detailing the synthesis of substituted furans. Most of the synthetic
methods are based on the addition of oxygen to the activated alkene,5 alkyne,6 or allene.7 Opening of the cyclopropane ring and cycloisomerization
in inter- or intramolecular fashion are also well-documented in the
literature.8 The majority of synthetic
methods require metals as reagents or catalysts such as Ag, Pd, Rh,
Cu, Pt, and Fe. A few methods starting from epoxides have also been
reported, requiring metallic catalysts including Ag, In, and Pt.9 However, a metal-free method is highly desired
to avoid metal impurities in the synthetic products, especially in
biologically relevant compounds.10 A few
methods other than the Paal–Knorr furan synthesis were developed
for the synthesis of substituted furans without metal catalysts.6c−6e,11

Most of them proceeded
in an intramolecular fashion with strong
acid or iodine as reagents. Some of the reactions required a prerequisite
of highly reactive intermediates including silyl enol ether, acid
chloride, and so forth.12 Thereby, a mild
and metal-free synthetic method for the preparation of multisubstituted
furan is highly desirable for further development of this useful heterocycle.

A few previous synthetic methods with the breakage of highly strained
cyclopropane or epoxide have been reported in the literature based
on the cycloisomerization.8,9 All of these methods
proceed by the intermediacy of A, which is more or less similar to
the reactive intermediate derived from the acyclic starting material.
Oxygen from the carbonyl group of the starting substrate adjacent
to cyclopropane or ring-opened epoxide attacks the activated alkynic
or allenic appendage with the assistance of metal catalysts such as
Cu, Ag, Au, and In.5−9 However, in this study, we developed a completely different method.
The suitably disposed carbonyl oxygen ended in the furan ring attacks
nonactivated aziridine which is activated by BF3·OEt2 followed by aromatization to yield furan. This strategy is
depicted as B in Figure 2. The cyclization with the opening of aziridine for a new heterocyclic
compound was observed in our early investigations.13 However, it has not been shown to make a new ring through
the cyclization with the breakage of the aziridine ring in an intramolecular
fashion. This extraordinary reaction pathway involving cyclization
by heteroatoms at the tether of the starting material with concomitant
breakage of the highly strained ring shows a possibility to develop
new methods for the preparation of various heterocycles.

Figure 2 Highly substituted
furan (1) and its general synthetic
method involving metal-mediated cyclization (A) compared to the method
(B) derived from the breakage of an aziridine ring.

The key for the
success is the breaking of the aziridine ring by
the nearby oxygen. Normally, most of the “activated”
aziridines readily react with the incoming nucleophile at the less
hindered site without any controllable regiochemical diversity.14 Another chemical method to make ring opening
easy is to design the starting substrate with olefin for allylic activation.15 Even though we have studied aziridine for quite
a long time,13 we were not able to open
the “unactivated” aziridine rings with the internal
oxygen so far because of the intrinsic inertness of the ring opening.
Aziridine in this synthesis is “unactivated” with the
electron-donating substituent at the ring nitrogen and is quite stable
and inert to almost all nucleophiles.15,16 These “unactivated”
aziridines should be activated before they react with nucleophiles.17 However, they have a big advantage on the regiochemical
diversity, that is, their ring can be opened either at C2 or at C3
and is completely controllable by the selection of activators and
nucleophiles.15−17

Results and Discussion
At first,
we prepared diethyl 2-(aziridin-2-ylmethylene)malonate
(2a) having suitably disposed carbonyl oxygen located
near aziridine being ready to attack for the ring opening. Initially,
aziridinyl malonate (2a) was treated with 1.05 equiv
of BF3·OEt2 and sodium acetate in CH2Cl2 at room temperature (rt) for 4 h to expect
the usual intermolecular aziridine ring-opening product 3a′. Much to our surprise, only intramolecular aziridine ring-opening
product 3a was formed in 85% yields without furnishing
any traces of the product arising from the intermolecular ring opening
(Scheme 1).

Scheme 1 Synthesis
of Multisubstituted Furan 3a from Diethyl
2-[((R)-(1-(R)-(1-Phenylethyl)aziridin-2-yl)methylene)]malonate
(2a)
Once the structure of furan 3a was confirmed,
the
same reaction was performed without using external nucleophile sodium
acetate and the same results were observed as above. To improve the
reaction yield for the conversion of aziridines to furan derivatives,
various Lewis acids such as AlCl3, CeCl3, I2, and/or FeCl3 were screened (Table 1). Among them, only BF3·OEt2 and FeCl3 yielded the expected product,
and BF3·OEt2 was the most effective.

Table 1 Formation of Multisubstituted Furans
(3a) from 2-(Aziridin-2-ylmethylene)malonate (2a) with Various Lewis Acids
entry	Lewis acid (1.05 equiv)	time (h)	yield (%)	
1	BF3·OEt2	3.0	85	
2	AlCl3	12.0	0	
3	CeCl3	4.0	0	
4	I2	12	0	
5	FeCl3	4.5	36	
Several
different aziridines were utilized for the intramolecular
ring-opening reaction, leading to the synthesis of various aminomethylfurans
in good to moderate yields (Table 2).

Table 2 Synthesis of Multisubstituted Furans
(3) from 2-(Aziridin-2-ylmethylene)malonate or 1,3-Dione
(2) with BF3·OEt2a
a Reaction conditions:
1,3-dione 2 (1.0 equiv) and BF3·OEt2 (1.05
equiv) in CH2Cl2 (0.3 M) at rt.

b Starting ketone 2p was
prepared in situ and directly converted to furan derivative 3p.

The optimized
reaction protocol was applied for the starting materials
with various substituents, that is, R1 at the nitrogen
of 2-(aziridin-2-ylmethylene)malonate and/or 1,3-dione including 2-phenylethyl
(2a, 2b, 2c, 2l, 2m, 2n, 2o, and 2p), benzyl (2d and 2e), t-butyl (2f, 2g, and 2h), c-hexyl (2i and 2j), and n-hexyl (2k) groups without altering the reaction
yields. No difference was observed in the reaction yields by changing
the alkyl esters (R3 and/or R4) of 2-(aziridin-2-ylmethylene)malonate,
whether they are methyl (2b and 2f), ethyl
(2a, 2d, 2g, 2i, 2l, and 2m), or i-Pr
(2c, 2e, 2h, 2j, and 2k). The same starting malonates decorated with
the additional methyl (2l, R2 = Me) and i-Pr (2m, R2 = i-Pr) groups at the β-position aiming for the substituent at
C4 of the furan ring yielded the expected products (3l and 3m) with the same efficiency. Under the same reaction
conditions, the starting substrate (2n) bearing ester
(R4 = OEt) and ketone (R3 = Me) at each side
(E-/Z-mixture) also afforded the
product (3n) in 80% yield. The product 3n retaining the methylcarbonyl group at the C3 position of furan suggested
us that the aziridine ring opening proceeded by more electron-rich
ester oxygen instead of the ketone oxygen. A striking feature of this
reaction was represented by the reactions with ketones, as shown in 2o (R3 and R4 = Me) and 2p (R3 and R4 = −CH2CH2CH2−) to produce furans 3o and 3p in 85 and 77% yields, respectively. The formation of these
products is ascribed to the breakage of the aziridine ring by ketone
oxygen. All of the reactions afforded the expected products in >75%
yield with complete conservation of the starting atoms to the products,
that is, with high degree of atom economy (Table 2).

A plausible mechanism of this reaction
is detailed in Scheme 2. Lewis acid activates
the aziridine ring (I) of the starting material 2 by coordinating with the lone pair electrons in the ring
nitrogen which was observed in our earlier study.18 At this stage, the ring is highly activated toward the
incoming nucleophile, that is, the suitably disposed carbonyl oxygen
with the breakage of the carbon–nitrogen bond in aziridine
as in I to yield II. This dominant regioselectivity
is directed by the allylic activation and by the preference of 5-exo-tet cyclization according to Baldwin’s rule.15,16,19 Then, the aromatization via deprotonation
of the acidic proton next to the aminomethyl substituent as in II afforded furan 3.

Scheme 2 Mechanism of the
Formation of Furan 3a and γ-Lactone 5 from Unsaturated Ester 2a and Saturated Ester 4, Respectively
A corroborating evidence of this mechanism was found from
the same
reaction with the saturated substrate, diethyl 2-(aziridin-2-ylmethyl)malonate 4, affording γ-lactone 5 instead of furan
(Scheme 2). When the
proton at C2 of aziridine is not acidic enough, dealkylation to form
γ-lactone 5 is more dominant rather than aromatization.
Therefore, furan 3 and lactone 5 from dialkyl
2-(aziridin-2-ylmethylene)malonate 2a and dialkyl 2-(aziridin-2-ylmethyl)malonate 4 were obtained from the similar intermediate I in the presence of Lewis acid BF3OEt2, respectively.
This reaction proceeded without any metallic additives as catalysts
or reagents with complete conservation of all of the starting atoms
to the products, that is, as a high degree of atom-economical synthesis.

Taking advantage of this synthetic method to get highly substituted
furan especially with aminomethyl appendage at C5, we treated aminomethylfuran 3b with 1.0 equiv of dimethyl acetylenedicarboxylate (DMAD)
and obtained Michael addition product 6 in quantitative
yields. The reaction of aminomethylfuran 3b with 2.0
equiv of DMAD afforded highly functionalized polycyclic compound 7 as a single isomer, confirmed by the NMR spectra (Scheme 3).

Scheme 3 Conversion of Furan 3b to Michael Adduct 6 and Polycyclic Compound 7
The crystalline structure
of the single stereoisomeric product 7 confirmed four
new stereocenters generated from the stereoselective
conjugate addition20 and cycloaddition
reactions.21 Furthermore, it should be
noted that all of the atoms in one furan and two acetylenedicarboxylates
are completely retained in the adduct without the loss of any atom.
On the basis of the above observation, the plausible reaction mechanism
for the formation of compound 7 from aminomethylfuran 3b via Michael adduct 6 is proposed (Scheme 4).

Scheme 4 Plausible Reaction
Mechanism for the Formation of Compound 7
Conclusions
In conclusion, we developed
a new synthetic method for highly substituted
furans from 2-(aziridin-2-ylmethylene)malonate and/or 1,3-dione via
aziridine ring opening by the internal carbonyl oxygen with the assistance
of BF3·OEt2 followed by aromatization.
This synthetic method is free from any metal and is highly atom-economical
with all of the atoms in the starting material retained in the final
product.

Experimental Section
General Information
Chiral aziridines
are available
from Sigma-Aldrich as reagents and from Imagene Co., Ltd. (http://www.imagene.co.kr/)
in bulk quantities. All commercially available compounds were used
as received unless stated otherwise. All reactions were carried out
under a nitrogen atmosphere in oven-dried glassware with a magnetic
stirrer. Dichloromethane was distilled from calcium hydride. Reactions
were monitored by thin-layer chromatography (TLC) with 0.25 mm E Merck
precoated silica gel plates (60 F254). Visualization was accomplished
either with UV light or by immersion in solutions of ninhydrin, p-anisaldehyde, or phosphomolybdic acid, followed by heating
on a hot plate for about 10 s. Purification of reaction products was
carried out by flash chromatography using Kieselgel 60 Art 9385 (230–400
mesh). 1H NMR and 13C NMR spectra were obtained
using a Varian unity lNOVA 400 WB (400 MHz) or Bruker AVANCE III HD
(400 MHz) spectrometer. Chemical shifts are reported relative to chloroform
(δ = 7.26) for 1H NMR and chloroform (δ = 77.2)
for 13C NMR and acetonitrile (δ = 1.94) for 1H NMR and acetonitrile (δ = 1.32) for 13C
NMR. Data are reported as (br = broad, s = singlet, d = doublet, t
= triplet, q = quartet, p = quintet, and m = multiplet). Coupling
constants are given in hertz. Ambiguous assignments were resolved
based on standard one-dimensional proton decoupling experiments. Optical
rotations were obtained using a RUDOLPH AUTOPOL III digital polarimeter
and a JASCO P-2000 polarimeter. Optical rotation data were reported
as follows: [α]20 (concentration c = g/100 mL, solvent). High-resolution mass spectra were recorded
on a 4.7 Tesla IonSpec ESI-TOFMS instrument, and JEOL (JMS-700) and
AB SCIEX 4800 Plus MALDI TOF (2,5-dihydroxybenzoic acid) matrix were
used to prepare samples for mass spectrometry. Data were obtained
in the reflector positive mode with internal standards for calibration.

General Procedure for the Synthesis of Multisubstituted Furan
(3)
To a stirred solution of dialkyl 2-(aziridin-2-ylmethylene)malonate
or 2-(aziridin-2-ylmethylene)-1,3-dione 2 (500 mg, 1.57
mmol) in CH2Cl2 (5.0 mL) was added BF3·OEt2 (0.20 mL, 1.65 mmol) at ambient temperature.
The reaction mixture was allowed to stir for 4 h (Table 2). After completion of the reaction
as confirmed by TLC (50% EtOAc/hexane), the mixture was quenched with
aq NaHCO3 (5.0 mL) and extracted with CH2Cl2 (10 × 3 mL). The combined organic layer was dried over
anhydrous Na2SO4, and the solvent was removed
in vacuo. This crude product was purified by column chromatography
to provide analytically pure furan 3.

(R)-Ethyl
2-Ethoxy-5-[(1-phenylethylamino)methyl]furan-3-carboxylate
(3a)
[α]D20 = +71.8 (c = 0.98, CHCl3); Rf = 0.48 (EtOAc/hexane, 50%); 1H NMR (400 MHz, CDCl3): δ 7.39–7.21
(m, 5H), 6.32 (s, 1H), 4.43 (q, J = 7.1 Hz, 2H),
4.25 (q, J = 7.1 Hz, 2H), 3.80 (q, J = 6.6 Hz, 1H), 3.50 (ABq, J = 14.8 Hz, 2H), 1.75
(br s, 1H), 1.45 (t, J = 7.1 Hz, 3H), 1.36 (d, J = 6.6 Hz, 3H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 101 MHz): δ 163.0, 161.2,
144.7, 143.4, 128.3, 126.9, 126.5, 108.2, 92.6, 67.9, 59.6, 56.6,
43.4, 24.1, 14.8, 14.2; HRMS-MALDI (m/z): [M + Na]+ calcd for C18H23NO4Na, 340.1520; found, 340.1537.

(R)-Methyl
2-Methoxy-5-[(1-phenylethylamino)methyl]-furan-3-carboxylate
(3b)
[α]D20 = +57.0 (c = 1.08, CHCl3); Rf = 0.40 (EtOAc/hexane, 50%); 1H NMR (400 MHz, CDCl3): δ 7.36–7.27
(m, 4H), 7.26–7.19 (m, 1H), 6.32 (s, 1H), 4.05 (s, 3H), 3.83–3.70
(m, 4H), 3.47 (ABq, J = 14.9 Hz, 2H), 1.70 (br s,
1H), 1.34 (d, J = 6.7 Hz, 3H); 13C NMR
(CDCl3, 101 MHz): δ 162.9, 161.1, 144.5, 143.3, 128.0,
126.6, 126.2, 108.1, 91.0, 57.6, 56.4, 50.6, 43.1, 23.9; HRMS-MALDI
(m/z): [M + Na]+ calcd
for C16H19NO4Na, 312.1207; found,
312.1203.

(R)-Isopropyl 2-Isopropoxy-5-[(1-phenylethylamino)-methyl]-furan-3-carboxylate
(3c)
[α]D20 = +57.7 (c = 1.65, CHCl3); Rf = 0.55 (EtOAc/hexane, 50%); 1H NMR (400 MHz, CDCl3): δ 7.36–7.29
(m, 4H), 7.27–7.22 (m, 1H), 6.30 (s, 1H), 5.18–5.07
(m, 1H), 4.93–4.83 (m, 1H), 3.79 (q, J = 6.6
Hz, 1H), 3.50 (ABq, J = 14.8 Hz, 2H), 1.73 (br s,
1H), 1.40 (d, J = 6.2 Hz, 6H), 1.35 (d, J = 6.6 Hz, 3H), 1.29 (d, J = 6.3 Hz, 6H); 13C NMR (CDCl3, 101 MHz): δ 162.7, 160.8, 144.8, 143.8,
128.4, 127.0, 126.6, 108.1, 95.1, 77.0, 66.9, 56.6, 43.6, 24.1, 22.3,
22.0; HRMS-MALDI (m/z): [M + Na]+ calcd for C20H27NO4Na, 368.1833;
found, 368.1820.

Ethyl 5-[(Benzylamino)methyl]-2-ethoxyfuran-3-carboxylate
(3d)
Rf = 0.40 (EtOAc/hexane,
50%); 1H NMR (400 MHz, CDCl3): δ 7.34–7.30
(m, 4H), 7.27–7.22 (m, 1H), 6.39 (s, 1H), 4.43 (q, J = 7.1 Hz, 2H), 4.25 (q, J = 7.1 Hz, 2H),
3.78 (s, 2H), 3.66 (d, J = 0.7 Hz, 2H), 1.73 (br
s, 1H), 1.44 (t, J = 7.1 Hz, 3H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 101
MHz): δ 163.0, 161.3, 143.2, 139.6, 128.3, 128.1, 127.0, 108.6,
92.7, 68.0, 59.7, 52.4, 45.0, 14.9, 14.3; HRMS-MALDI (m/z): [M + Na]+ calcd for C17H21NO4Na, 326.1363; found, 326.1352.

Isopropyl
5-[(Benzylamino)methyl]-2-isopropoxyfuran-3-carboxylate
(3e)
Rf = 0.60 (EtOAc/hexane,
50%); 1H NMR (400 MHz, CDCl3): δ 7.35–7.27
(m, 4H), 7.26–7.20 (m, 1H), 6.39 (s, 1H), 5.18–5.08
(m, 1H), 4.94–4.84 (m, 1H), 3.76 (s, 2H), 3.64 (s, 2H), 1.77
(br s, 1H), 1.40 (d, J = 6.2 Hz, 6H), 1.29 (d, J = 6.3 Hz, 6H); 13C NMR (CDCl3, 101
MHz): δ 162.4, 160.6, 143.4, 139.5, 128.1, 127.9, 126.7, 108.1,
94.9, 76.8, 66.6, 52.2, 44.8, 22.1, 21.7; HRMS-MALDI (m/z): [M + Na]+ calcd for C19H25NO4Na, 354.1676; found, 354.1660.

Methyl
5-[(tert-Butylamino)methyl]-2-methoxyfuran-3-carboxylate
(3f)
Rf = 0.50 (EtOAc/hexane,
50%); 1H NMR (400 MHz, CDCl3): δ 6.38
(s, 1H), 4.10 (s, 3H), 3.80 (s, 3H), 3.64 (d, J =
0.7 Hz, 2H), 1.60 (br s, 1H), 1.15 (s, 9H); 13C NMR (CDCl3, 101 MHz): δ 163.4, 161.4, 144.3, 107.9, 91.6, 58.1,
51.1, 50.6, 39.6, 28.8; HRMS-MALDI (m/z): [M + Na]+ calcd for C12H19NO4Na, 264.1207; found, 264.1214.

Ethyl 5-[(tert-Butylamino)methyl]-2-ethoxyfuran-3-carboxylate
(3g)
Rf = 0.40 (EtOAc/hexane,
50%); 1H NMR (400 MHz, CDCl3): δ 6.39
(s, 1H), 4.44 (q, J = 7.1 Hz, 2H), 4.25 (q, J = 7.1 Hz, 2H), 3.64 (d, J = 0.7 Hz, 2H),
1.76 (br s, 1H), 1.45 (t, J = 7.1 Hz, 3H), 1.32 (t, J = 7.1 Hz, 3H), 1.16 (s, 9H); 13C NMR (CDCl3, 101 MHz): δ 163.1, 161.3, 144.1, 107.7, 93.0, 68.2,
59.7, 50.7, 39.7, 28.8, 14.9, 14.3; HRMS-MALDI (m/z): [M + Na]+ calcd for C14H23NO4Na, 292.1520; found, 292.1534.

Isopropyl
5-[(tert-Butylamino)methyl]-2-isopropoxyfuran-3-carboxylate
(3h)
Rf = 0.50 (EtOAc/hexane,
50%); 1H NMR (400 MHz, CDCl3): δ 6.37
(s, 1H), 5.18–5.07 (m, 1H), 4.96–4.85 (m, 1H), 3.64
(d, J = 0.6 Hz, 2H), 1.77 (br s, 1H), 1.40 (d, J = 6.2 Hz, 6H), 1.29 (d, J = 6.3 Hz, 6H),
1.15 (s, 9H); 13C NMR (CDCl3, 101 MHz): δ
162.7, 160.7, 144.5, 107.4, 95.3, 77.1, 66.9, 50.6, 39.7, 28.8, 22.3,
21.9; HRMS-MALDI (m/z): [M + Na]+ calcd for C16H27NO4Na, 320.1833;
found, 320.1848.

Ethyl 5-[(Cyclohexylamino)methyl]-2-ethoxyfuran-3-carboxylate
(3i)
Rf = 0.40 (EtOAc/hexane,
50%); 1H NMR (400 MHz, CDCl3): δ 6.38
(s, 1H), 4.43 (q, J = 7.1 Hz, 2H), 4.25 (q, J = 7.1 Hz, 2H), 3.69 (s, 2H), 2.51–2.40 (m, 1H),
1.91–1.83 (m, 2H), 1.79 (br s, 1H), 1.77–1.70 (m, 2H),
1.65–1.57 (m, 1H), 1.44 (t, J = 7.1 Hz, 3H),
1.32 (t, J = 7.1 Hz, 3H), 1.27–1.16 (m, 3H),
1.15–1.04 (m, 2H); 13C NMR (CDCl3, 101
MHz): δ 163.1, 161.3, 143.5, 108.3, 92.8, 68.0, 59.8, 55.3,
42.8, 33.1, 26.0, 24.8, 14.9, 14.3; HRMS-MALDI (m/z): [M + Na]+ calcd for C16H25NO4Na, 318.1676; found, 318.1677.

Isopropyl
5-[(Cyclohexylamino)methyl]-2-isopropoxyfuran-3-carboxylate
(3j)
Rf = 0.60 (EtOAc/hexane,
50%); 1H NMR (400 MHz, CDCl3): δ 6.35
(s, 1H), 5.17–5.07 (m, 1H), 4.89 (sep, J =
6.2 Hz, 1H), 3.68 (d, J = 0.6 Hz, 2H), 2.44 (tt, J = 10.3, 3.8 Hz, 1H), 1.89–1.81 (m, 2H), 1.77 (br
s, 1H), 1.75–1.68 (m, 2H), 1.65–1.57 (m, 1H), 1.40 (d, J = 6.2 Hz, 6H), 1.29 (d, J = 6.3 Hz, 6H),
1.27–1.16 (m, 3H), 1.15–1.03 (m, 2H); 13C
NMR (CDCl3, 101 MHz): δ 162.7, 160.7, 144.1, 107.9,
95.1, 77.0, 66.9, 55.1, 42.8, 33.1, 25.9, 24.8, 22.3, 21.9; HRMS-MALDI
(m/z): [M + Na]+ calcd
for C18H29NO4Na, 346.1990; found,
346.2002.

Isopropyl 5-[(Hexylamino)methyl]-2-isopropoxyfuran-3-carboxylate
(3k)
Rf = 0.60 (EtOAc/hexane,
50%); 1H NMR (400 MHz, CDCl3): δ 6.40
(s, 1H), 5.17–5.07 (m, 1H), 4.96–4.86 (m, 1H), 3.68
(s, 2H), 2.60 (t, J = 7.3 Hz, 2H), 2.12 (br s, 1H),
1.55–1.46 (m, 2H), 1.40 (d, J = 6.2 Hz, 6H),
1.33–1.24 (m, 12H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR (CDCl3, 101 MHz): δ 162.7, 160.9,
108.7, 95.1, 77.1, 67.0, 48.5, 45.6, 31.6, 29.6, 29.5, 26.9, 22.5,
22.3, 22.0, 13.9; HRMS-MALDI (m/z): [M + Na]+ calcd for C18H31NO4Na, 348.2146; found, 348.2153.

(R)-Ethyl
2-Ethoxy-4-methyl-5-[(1-phenylethylamino)-methyl]furan-3-carboxylate
(3l)
[α]D20 = +44.0 (c = 1.14, CHCl3); Rf = 0.50 (EtOAc/hexane, 50%); 1H NMR (400 MHz, CDCl3): δ 7.38–7.29
(m, 4H), 7.27–7.22 (m, 1H), 4.39 (q, J = 7.1
Hz, 2H), 4.25 (q, J = 7.1 Hz, 2H), 3.75 (q, J = 6.6 Hz, 1H), 3.50 (ABq, J = 14.7 Hz,
2H), 2.36 (br s, 1H), 1.95 (s, 3H), 1.43 (t, J =
7.1 Hz, 3H), 1.37–1.29 (m, 6H); 13C NMR (CDCl3, 101 MHz): δ 163.8, 161.6, 144.7, 139.1, 128.4, 127.0,
126.6, 118.1, 92.7, 67.4, 59.4, 56.6, 40.8, 24.2, 14.9, 14.3, 10.0;
HRMS-MALDI (m/z): [M + Na]+ calcd for C19H25NO4Na, 354.1676;
found, 354.1669.

(R)-Ethyl 2-Ethoxy-4-isopropyl-5-[(1-phenylethylamino)-methyl]furan-3-carboxylate
(3m)
[α]D20 = +18.5 (c = 0.97, CHCl3); Rf = 0.55 (EtOAc/hexane, 50%); 1H NMR (400 MHz, CDCl3): δ 7.37–7.30
(m, 4H), 7.28–7.22 (m, 1H), 4.36 (q, J = 7.1
Hz, 2H), 4.25 (q, J = 7.1 Hz, 2H), 3.77 (q, J = 6.6 Hz, 1H), 3.55 (ABq, J = 14.6 Hz,
2H), 3.15–3.04 (m, 1H), 1.87 (br s, 1H), 1.42 (t, J = 7.1 Hz, 3H), 1.36–1.30 (m, 6H), 1.22–1.17 (m, 6H); 13C NMR (CDCl3, 101 MHz): δ 163.7, 161.7,
145.0, 138.9, 128.4, 128.0, 127.0, 126.6, 92.0, 67.3, 59.5, 56.9,
42.3, 24.8, 24.3, 22.1, 14.9, 14.3; HRMS-MALDI (m/z): [M + Na]+ calcd for C21H29NO4Na, 382.1990; found, 382.2005.

(R)-1-(2-Ethoxy-5-[(1-phenylethylamino)methyl]furan-3-yl)ethanone
(3n)
[α]D20 = +69.0 (c = 1.07, CHCl3); Rf = 0.40 (EtOAc/hexane, 50%); 1H NMR (400 MHz, CDCl3): δ 7.38–7.29
(m, 4H), 7.28–7.21 (m, 1H), 6.38 (s, J = 3.9
Hz, 1H), 4.48–4.41 (m, 2H), 3.79 (q, J = 6.6
Hz, 1H), 3.50 (ABq, J = 14.9 Hz, 2H), 2.36 (s, 3H),
1.79 (br s, 1H), 1.46 (t, J = 7.1 Hz, 3H), 1.35 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 101
MHz): δ 191.4, 161.3, 144.7, 144.1, 128.3, 126.9, 126.5, 107.2,
102.4, 67.3, 56.6, 43.4, 28.3, 24.1, 14.8; HRMS-MALDI (m/z): [M + Na]+ calcd for C17H21NO3Na, 310.1414; found, 310.1413.

(R)-1-(2-Methyl-5-[(1-phenylethylamino)methyl]furan-3-yl]ethanone
(3o)
[α]D20 = +53.3 (c = 4.12, CHCl3); Rf = 0.45 (EtOAc/hexane, 50%); 1H NMR (400 MHz, CDCl3): δ 7.39–7.16
(m, 5H), 6.31 (s, 1H), 3.79 (q, J = 6.6 Hz, 1H),
3.56 (ABq, J = 14.6 Hz, 2H), 2.54 (s, 3H), 2.34 (s,
3H), 1.74 (br s, 1H), 1.36 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 101 MHz): δ 193.7, 157.3,
151.6, 144.5, 128.2, 126.7, 126.3, 121.5, 107.1, 56.9, 43.4, 28.7,
24.0, 14.0; HRMS-MALDI (m/z): [M
+ Na]+ calcd for C16H19NO2Na, 280.1308; found, 280.1300.

(R)-2-[(1-Phenylethylamino)methyl]-6,7-dihydrobenzofuran-4(5H)-one (3p)
Piperidine (10 μL,
0.1 mmol) was added to a stirred solution of aziridinyl aldehyde (175
mg, 1.0 mmol), cyclohexane-1,3-dione (118 mg, 1.05 mmol), and 4 Å
molecular sieves (dry powder, 0.2 g) in CH2Cl2 (4.0 mL) at rt, and the reaction mixture was allowed to stir for
12 h. BF3·OEt2 (0.16 mL, 1.3 mmol) was
added to the reaction mixture and stirred for 6.0 h. The reaction
mixture was filtered through Celite and washed with CH2Cl2 (3 × 15 mL). The combined organic layer was washed
with aq NaHCO3 (5.0 mL), and the solvents were removed
under vacuum to get a crude product, which was purified by column
chromatography on silica gel to get pure product 3p (207
mg, 77%). [α]D20 = +73.6 (c = 1.02, CHCl3); Rf = 0.40 (EtOAc/hexane, 50%); 1H
NMR (400 MHz, CDCl3): δ 7.36–7.18 (m, 5H),
6.35 (s, 1H), 3.78 (q, J = 6.6 Hz, 1H), 3.58 (ABq, J = 14.7 Hz, 2H), 2.80 (t, J = 6.3 Hz,
2H), 2.46–2.38 (m, 2H), 2.15–2.04 (m, 2H), 1.82 (br
s, 1H), 1.34 (d, J = 6.7 Hz, 3H); 13C
NMR (CDCl3, 101 MHz): δ 193.7, 166.1, 153.9, 144.3,
128.0, 126.5, 126.2, 121.2, 102.9, 56.5, 43.2, 37.0, 23.8, 22.8, 22.1;
HRMS-MALDI (m/z): [M + Na]+ calcd for C17H19NO2Na, 270.1489;
found, 270.1477.

(R)-Ethyl 2-Oxo-5-[(1-phenylethylamino)methyl]tetrahydro-furan-3-carboxylate
(5)
Procedure A
BF3·OEt2 (0.16
mL, 1.3 mmol) was added to a solution of ester 4 (160
mg, 0.5 mmol) in CH2Cl2 (4.0 mL), and the mixture
was stirred for 24 h at rt. The reaction mixture was quenched with
aq NaHCO3 and extracted with CH2Cl2, and the combined organic layer was dried over Na2SO4. The solvents were removed under vacuum to get a crude product,
which was purified by column chromatography to yield pure lactone 5 (81 mg, 56%).

Procedure B
BF3·OEt2 (0.16
mL, 1.3 mmol) was added to a solution of ester 4 (160
mg, 0.5 mmol) in acetonitrile (4.0 mL), and the mixture was refluxed
for 2.0 h at 90 °C. The reaction mixture was cooled to rt and
quenched with aq NaHCO3. The reaction mixture was extracted
with CH2Cl2 (3 × 10 mL), the combined organic
layer was dried over Na2SO4, and the solvents
were removed under vacuum to get a crude product, which was purified
by column chromatography to yield pure lactone 5 (125
mg, 86%). Rf = 0.30 (EtOAc/hexane, 50%); 1H NMR (400 MHz, CD3CN): δ 7.37–7.30
(m, 4H), 7.27–7.20 (m, 1H), 4.68–4.59 (m, 0.5H), 4.55–4.46
(m, 0.5H), 4.24–4.13 (m, 2H), 3.76 (dq, J =
10.2, 6.6 Hz, 1H), 3.67 (dt, J = 10.6, 8.1 Hz, 1H),
2.81–2.71 (m, 1H), 2.61–2.21 (m, 3H), 2.12 (br s, 1H),
1.33–1.21 (m, 6H); HRMS-MALDI (m/z): [M + Na]+ calcd for C16H21NO4Na, 314.1363; found, 314.1373.

(R)-Dimethyl 2-[((5-Methoxy-4-(methoxycarbonyl)furan-2-yl)methyl)(1-phenylethyl)amino]-maleate
(6)
A mixture of aminomethylfuran 3b (200 mg, 0.69 mmol) and DMAD (84 μL, 0.69 mmol) in a sealed
tube was stirred for 1 h at 90 °C. The reaction mixture was purified
by column chromatography to get pure compound 6 (288
mg, 97% yield). [α]D20 = +66.7 (c = 1.0, CHCl3); Rf = 0.40 (EtOAc/hexane, 50%); 1H NMR (400 MHz, CDCl3): δ 7.45–7.25
(m, 5H), 6.25 (s, 1H), 4.86 (s, 1H), 4.78 (q, J =
6.8 Hz, 1H), 4.02 (s, 3H), 3.96 (s, 3H), 3.92 (s, 2H), 3.76 (s, 3H),
3.64 (s, 3H), 1.64 (d, J = 6.9 Hz, 3H); 13C NMR (CDCl3, 101 MHz): δ 167.8, 166.0, 163.0, 161.0,
153.7, 138.7, 138.6, 128.6, 128.0, 127.3, 110.2, 91.5, 86.4, 58.7,
57.9, 53.0, 51.1, 50.8, 41.5, 17.0; HRMS-MALDI (m/z): [M + Na]+ calcd for C22H25NO8Na, 454.1473; found, 454.1460.

(4aS,5R,6S,8aR)-Pentamethyl 6-Methoxy-2-((R)-1-phenylethyl)-2,4a,5,6-tetrahydro-1H-6,8a-epoxyisoquinoline-3,4,5,7,8-pentacarboxylate
(7)
A mixture of aminomethylfuran 3b (200 mg, 0.69 mmol) and DMAD (0.17 mL, 1.4 mmol) in a sealed tube
was stirred for 12 h at 90 °C. The reaction mixture was purified
by column chromatography to get pure compound 7 (285
mg, 72% yield). [α]D20 = +1.6 (c = 0.62, CHCl3); Rf = 0.35 (EtOAc/hexane, 50%); 1H NMR (400 MHz, CDCl3): δ 7.43–7.28
(m, 5H), 4.68 (q, J = 6.8 Hz, 1H), 3.94 (s, 3H),
3.79 (s, 3H), 3.73 (s, 3H), 3.72 (s, 3H), 3.59 (s, 3H), 3.54 (s, 3H),
3.25 (ABq, J = 14.4 Hz, 2H), 3.11 (d, J = 4.2 Hz, 1H), 3.03 (d, J = 4.2 Hz, 1H), 1.56 (d, J = 6.8 Hz, 3H); 13C NMR (CDCl3, 101
MHz): δ 170.6, 167.1, 166.2, 162.3, 162.0, 148.1, 145.5, 141.0,
138.4, 128.7, 128.0, 127.5, 112.6, 96.7, 80.1, 58.2, 57.3, 54.8, 53.0,
52.6, 52.4, 52.2, 51.0, 44.4, 41.5, 17.3; HRMS-MALDI (m/z): [M + Na]+ calcd for C28H31NO12Na, 574.1920; found, 574.1913.

Supporting Information Available
The Supporting Information is
available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.7b01542.General experimental
procedures for starting materials
(2a–2o), 1H and 13C NMR
spectra of all prepared compounds, and X-ray crystallographic data
for compound 7 (PDF)



Supplementary Material
ao7b01542_si_001.pdf

 The authors
declare no competing financial interest.

Acknowledgments
This work was supported
by the National Research
Foundation of Korea (NRF-2012M3A7B4049645 and 2014R1A5A1011165 with
Centre for New Directions in Organic Synthesis).
==== Refs
References
a Krishna Y. ; Sharma S. ; Ampapathi R. S. ; Koley D. 
Org.
Lett. 
2014 , 16 , 2084 10.1021/ol5002126 .24697707  b Méndez-Andino J. ; Paquette L. A. 
Org. Lett. 
2000 , 2 , 4095 10.1021/ol000325k .11112652  c Chakraborty T. K. ; Arora A. ; Roy S. ; Kumar N. ; Maiti S. 
J. Med. Chem. 
2007 , 50 , 5539 10.1021/jm070619c .17927166  d Kobayashi J. ; Ohizumi Y. ; Nakamura H. ; Hirata Y. 
Tetrahedron Lett. 
1986 , 27 , 2113 10.1016/s0040-4039(00)84462-7 . e Flynn B. L. ; Hamel E. ; Jung M. K. 
J. Med. Chem. 
2002 , 45 , 2670 10.1021/jm020077t .12036378  f Gulevich A.
V. ; Dudnik A. S. ; Chernyak N. ; Gevorgyan V. 
Chem. Rev. 
2013 , 113 , 3084 10.1021/cr300333u .23305185  g Manna S. ; Antonchick A. P. 
Org. Lett. 
2015 , 17 , 4300 10.1021/acs.orglett.5b02114 .26277912 
a Cheng X. ; Yu Y. ; Mao Z. ; Chen J. ; Huang X. 
Org.
Biomol. Chem. 
2016 , 14 , 3878 10.1039/c6ob00377j .26952826  b Marshall J. A. ; McNulty L. M. ; Zou D. 
J. Org. Chem. 
1999 , 64 , 5193 10.1021/jo990376z . c Marshall J.
A. ; Liao J. 
J. Org. Chem. 
1998 , 63 , 5962 10.1021/jo980603h .11672200  d Hou X. L. ; Cheung H. Y. ; Hon T. Y. ; Kwan P. L. ; Lo T. H. ; Tong S. Y. ; Wong H. N. C. 
Tetrahedron 
1998 , 54 , 1955 10.1016/s0040-4020(97)10303-9 . e Reichstein A. ; Vortherms S. ; Bannwitz S. ; Tentrop J. ; Prinz H. ; Müller K. 
J. Med. Chem. 
2012 , 55 , 7273 10.1021/jm3009597 .22845014  f Tsuji H. ; Mitsui C. ; Ilies L. ; Sato Y. ; Nakamura E. 
J. Am. Chem. Soc. 
2007 , 129 , 11902 10.1021/ja074365w .17850088  g Chatterjee M. ; Ishizaka T. ; Kawanami H. 
Green Chem. 
2016 , 18 , 487 10.1039/c5gc01352f . h Martínez J. J. ; Nope E. ; Rojas H. ; Brijaldo M. H. ; Passos F. ; Romanelli G. 
J. Mol. Catal. A: Chem. 
2014 , 392 , 235 10.1016/j.molcata.2014.05.014 . i Albrecht Ł. ; Ransborg L. K. ; Gschwend B. ; Jørgensen K. A. 
J. Am. Chem. Soc. 
2010 , 132 , 17886 10.1021/ja108247t .21128688 
a Lipshutz B. H. 
Chem. Rev. 
1986 , 86 , 795 10.1021/cr00075a005 . b Gabriele B. ; Salerno G. ; Lauria E. 
J. Org. Chem. 
1999 , 64 , 7687 10.1021/jo990847h .
a Kobayashi Y. ; Nakano M. ; Kumar G. B. ; Kishihara K. 
J. Org. Chem. 
1998 , 63 , 7505 10.1021/jo980942a .11672404  b Paquette L. A. ; Doherty A. M. ; Rayner C. M. 
J. Am. Chem. Soc. 
1992 , 114 , 3910 10.1021/ja00036a045 . c Shimizu Y. 
Chem. Rev. 
1993 , 93 , 1685 10.1021/cr00021a002 . d Paquette L. A. ; Astles P. C. 
J. Org. Chem. 
1993 , 58 , 165 10.1021/jo00053a031 . e Tanis S. P. ; Robinson E. D. ; McMills M. C. ; Watt W. 
J.
Am. Chem. Soc. 
1992 , 114 , 8349 10.1021/ja00048a003 . f Kirsch S. F. 
Org. Biomol. Chem. 
2006 , 4 , 2076 10.1039/b602596j .16729118  g Fürstner A. ; Nagano T. 
J. Am. Chem. Soc. 
2007 , 129 , 1906 10.1021/ja068901g .17253696 
a Zhang X. ; Dai W. ; Wu W. ; Cao S. 
Org. Lett. 
2015 , 17 , 2708 10.1021/acs.orglett.5b01123 .25988867  b Schmidt D. ; Malakar C. C. ; Beifuss U. 
Org. Lett. 
2014 , 16 , 4862 10.1021/ol502371j .25192074 
a Minkler S. R. K. ; Isley N. A. ; Lippincott D. J. ; Krause N. ; Lipshutz B. H. 
Org. Lett. 
2014 , 16 , 724 10.1021/ol403402h .24433154  b Kramer S. ; Madsen J. L. H. ; Rottländer M. ; Skrydstrup T. 
Org. Lett. 
2010 , 12 , 2758 10.1021/ol1008685 .20462239  c Chen Z. ; Huang G. ; Jiang H. ; Huang H. ; Pan X. 
J. Org. Chem. 
2011 , 76 , 1134 10.1021/jo1023987 .21235260  d Wang T. ; Chen X.-l. ; Chen L. ; Zhan Z.-p. 
Org. Lett. 
2011 , 13 , 3324 10.1021/ol201054z .21648402  e Sniady A. ; Wheeler K. A. ; Dembinski R. 
Org. Lett. 
2005 , 7 , 1769 10.1021/ol050372i .15844902  f Egi M. ; Azechi K. ; Akai S. 
Org. Lett. 
2009 , 11 , 5002 10.1021/ol901942t .19780532  g Cao H. ; Zhan H. ; Cen J. ; Lin J. ; Lin Y. ; Zhu Q. ; Fu M. ; Jiang H. 
Org. Lett. 
2013 , 15 , 1080 10.1021/ol400080e .23413974  h Cao H. ; Jiang H. ; Yao W. ; Liu X. 
Org. Lett. 
2009 , 11 , 1931 10.1021/ol900364y .19323564  i Li J. ; Liu L. ; Ding D. ; Sun J. ; Ji Y. ; Dong J. 
Org. Lett. 
2013 , 15 , 2884 10.1021/ol401239j .23687935  j Hashmi A. S. K. ; Schwarz L. ; Choi J.-H. ; Frost T. M. 
Angew. Chem.,
Int. Ed. 
2000 , 39 , 2285 10.1002/1521-3773(20000703)39:13<2285::aid-anie2285>3.0.co;2-f .
a Cheng C. ; Liu S. ; Zhu G. 
Org. Lett. 
2015 , 17 , 1581 10.1021/acs.orglett.5b00464 .25763599  b Cheng C. ; Liu S. ; Zhu G. 
J.
Org. Chem. 
2015 , 80 , 7604 10.1021/acs.joc.5b01182 .26147649  c Kim H. Y. ; Li J.-Y. ; Oh K. 
J. Org. Chem. 
2012 , 77 , 11132 10.1021/jo302253c .23198987  d Hosseyni S. ; Su Y. ; Shi X. 
Org. Lett. 
2015 , 17 , 6010 10.1021/acs.orglett.5b02980 .26634310  e Sromek A. W. ; Rubina M. ; Gevorgyan V. 
J. Am. Chem. Soc. 
2005 , 127 , 10500 10.1021/ja053290y .16045332  f Hosseyni S. ; Su Y. ; Shi X. 
Org. Lett. 
2015 , 17 , 6010 10.1021/acs.orglett.5b02980 .26634310  g Dudnik A. S. ; Gevorgyan V. 
Angew. Chem., Int. Ed. 
2007 , 46 , 5195 10.1002/anie.200701128 .
a Zhang J. ; Schmalz H.-G. 
Angew. Chem., Int. Ed. 
2006 , 45 , 6704 10.1002/anie.200601252 . b Bai Y. ; Fang J. ; Ren J. ; Wang Z. 
Chem.—Eur.
J. 
2009 , 15 , 8975 10.1002/chem.200901133 .19644986  c Bai Y. ; Tao W. ; Ren J. ; Wang Z. 
Angew. Chem., Int. Ed. 
2012 , 51 , 4112 10.1002/anie.201200450 . d Blanc A. ; Bénéteau V. ; Weibel J.-M. ; Pale P. 
Org. Biomol. Chem. 
2016 , 14 , 9184 10.1039/c6ob01468b .27722719 
a Yoshida M. ; Al-Amin M. ; Shishido K. 
Synthesis 
2009 , 2454 10.1055/s-0029-1216867 . b Blanc A. ; Tenbrink K. ; Weibel J.-M. ; Pale P. 
J. Org. Chem. 
2009 , 74 , 4360 10.1021/jo900483m .19400569  c Kang J. Y. ; Connell B. T. 
J. Org. Chem. 
2011 , 76 , 2379 10.1021/jo2001353 .21384932  d Shu X.-Z. ; Liu X.-Y. ; Xiao H.-Q. ; Ji K.-G. ; Guo L.-N. ; Qi C.-Z. ; Liang Y.-M. 
Adv. Synth. Catal. 
2007 , 349 , 2493 10.1002/adsc.200700319 . e Ji K.-G. ; Shen Y.-W. ; Shu X.-Z. ; Xiao H.-Q. ; Bian Y.-J. ; Liang Y.-M. 
Adv. Synth. Catal. 
2008 , 350 , 1275 10.1002/adsc.200800130 . f Hashmi A. S. K. ; Sinha P. 
Adv. Synth. Catal. 
2004 , 346 , 432 10.1002/adsc.200303201 . g Blanc A. ; Tenbrink K. ; Weibel J.-M. ; Pale P. 
J.
Org. Chem. 
2009 , 74 , 5342 10.1021/jo9008172 .19572586  h Shiroodi R. K. ; Koleda O. ; Gevorgyan V. 
J. Am. Chem. Soc. 
2014 , 136 , 13146 10.1021/ja507054j .25198147 
a Baars H. ; Beyer A. ; Kohlhepp S. V. ; Bolm C. 
Org.
Lett. 
2014 , 16 , 536 10.1021/ol403414v .24364511  b Youn S. W. ; Lee E. M. 
Org. Lett. 
2016 , 18 , 5728 10.1021/acs.orglett.6b02994 .27775364  c Kovvuri J. ; Nagaraju B. ; Kamal A. ; Srivastava A. K. 
ACS Comb. Sci. 
2016 , 18 , 644 10.1021/acscombsci.6b00107 .27631587  d Tsujii M. ; Sonoda M. ; Tanimori S. 
J. Org. Chem. 
2016 , 81 , 6766 10.1021/acs.joc.6b00651 .27388021  e Yang D. ; Yan K. ; Wei W. ; Tian L. ; Li Q. ; You J. ; Wang H. 
RSC Adv. 
2014 , 4 , 48547 10.1039/c4ra08260e .
a Zhan Z.-p. ; Cai X.-b. ; Wang S.-p. ; Yu J.-l. ; Liu H.-j. ; Cui Y.-y. 
J. Org. Chem. 
2007 , 72 , 9838 10.1021/jo701782g .17997572  b Du X. ; Chen H. ; Chen Y. ; Chen J. ; Liu Y. 
Synlett 
2011 , 7 , 1010 10.1055/s-0030-1259717 . c Li L. ; Zhao M.-N. ; Ren Z.-H. ; Li J. ; Guan Z.-H. 
Synthesis 
2012 , 44 , 532 10.1055/s-0031-1289993 . d Fan M. ; Yan Z. ; Liu W. ; Liang Y. 
J. Org. Chem. 
2005 , 70 , 8204 10.1021/jo050903g .16277350  e Yadav J. S. ; Reddy B. V. S. ; Shubashree S. ; Sadashiv K. ; Naidu J. J. 
Synthesis 
2004 , 2376 10.1055/s-2004-831181 .
a Chen L. ; Du Y. ; Zeng X.-P. ; Shi T.-D. ; Zhou F. ; Zhou J. 
Org. Lett. 
2015 , 17 , 1557 10.1021/acs.orglett.5b00442 .25730110  b Kao T.-T. ; Syu S.-e. ; Jhang Y.-W. ; Lin W. 
Org.
Lett. 
2010 , 12 , 3066 10.1021/ol101080q .20521775 
a Choi H. G. ; Kwon J. H. ; Kim J. C. ; Lee W. K. ; Eum H. ; Ha H.-J. 
Tetrahedron Lett. 
2010 , 51 , 3284 10.1016/j.tetlet.2010.04.069 . b Lee H. ; Kim J. H. ; Lee W. K. ; Cho J. ; Nam W. ; Lee J. ; Ha H.-J. 
Org. Biomol. Chem. 
2013 , 11 , 3629 10.1039/c3ob27390c .23538672  c Lee H. ; Kim H. J. ; Lee W. K. ; Jung J.-H. ; Ha H.-J. 
Org.
Lett. 
2012 , 14 , 3120 10.1021/ol301187s .22667999  d Singh A. ; Kim B. ; Lee W. K. ; Ha H.-J. 
Org. Biomol. Chem. 
2011 , 9 , 1372 10.1039/c0ob00730g .21206946  e Sim T. B. ; Kang S. H. ; Lee K. S. ; Lee W. K. ; Yun H. ; Dong Y. ; Ha H.-J. 
J. Org. Chem. 
2003 , 68 , 104 10.1021/jo0261911 .12515467  f Kim M. S. ; Kim Y.-W. ; Hahm H. S. ; Jang J. W. ; Lee W. K. ; Ha H.-J. 
Chem. Commun. 
2005 , 3062 10.1039/b503750f . g Park C. S. ; Kim M. S. ; Sim T. B. ; Pyun D. K. ; Lee C. H. ; Choi D. ; Lee W. K. ; Chang J.-W. ; Ha H.-J. 
J.
Org. Chem. 
2003 , 68 , 43 10.1021/jo025545l .12515459  h Kim M. S. ; Yoon H. J. ; Lee B. K. ; Kwon J. H. ; Lee W. K. ; Kim Y. ; Ha H.-J. 
Synlett 
2005 , 2187 10.1055/s-2005-871974 .
a Sapse A. M. ; Bunce J. D. ; Jain D. C. 
J. Am. Chem. Soc. 
1984 , 106 , 6579 10.1021/ja00334a021 . b Singh G. S. ; D’hooghe M. ; De Kimpe N. 
Chem. Rev. 
2007 , 107 , 2080 10.1021/cr0680033 .17488062  c Sweeney J.
B. 
Chem. Soc. Rev. 
2002 , 31 , 247 10.1039/b006015l .12357722  d Watson I. D. G. ; Yu L. ; Yudin A. K. 
Acc. Chem. Res. 
2006 , 39 , 194 10.1021/ar050038m .16548508  e Florio S. ; Luisi R. 
Chem. Rev. 
2010 , 110 , 5128 10.1021/cr100032b .20469946 
a Stanković S. ; D’hooghe M. ; Catak S. ; Eum H. ; Waroquier M. ; Van Speybroeck V. ; De Kimpe N. ; Ha H.-J. 
Chem. Soc. Rev. 
2012 , 41 , 643 10.1039/c1cs15140a .21894345  b D’hooghe M. ; Catak S. ; Stanković S. ; Waroquier M. ; Kim Y. ; Ha H.-J. ; Van Speybroeck V. ; De Kimpe N. 
Eur. J. Org. Chem. 
2010 , 4920 10.1002/ejoc.201000486 .
a Kim Y. ; Ha H.-J. ; Yun S. Y. ; Lee W. K. 
Chem. Commun. 
2008 , 4363 10.1039/b809124b . b D’hooghe M. ; Van Speybroeck V. ; Waroquier M. ; De Kimpe N. 
Chem. Commun. 
2006 , 1554 10.1039/b518298k .
a Choi J. ; Yadav N. N. ; Ha H.-J. 
Asian J. Org.
Chem. 
2017 , 6 , 1292 –1307 . 10.1002/ajoc.201700080 . b Dolfen J. ; Yadav N. N. ; De Kimpe N. ; D’hooghe M. ; Ha H.-J. 
Adv.
Synth. Catal. 
2016 , 358 , 3485 10.1002/adsc.201600750 . c Ji M.-K. ; Hertsen D. ; Yoon D.-H. ; Eum H. ; Goossens H. ; Waroquier M. ; Van Speybroeck V. ; D’hooghe M. ; De Kimpe N. ; Ha H.-J. 
Chem.—Asian J. 
2014 , 9 , 1060 10.1002/asia.201301551 .24488926  d Métro T.-X. ; Duthion B. ; Pardo D. G. ; Cossy J. 
Chem. Soc. Rev. 
2010 , 39 , 89 10.1039/b806985a .20023840  e Yoon D.-H. ; Kang P. ; Lee W. K. ; Kim Y. ; Ha H.-J. 
Org. Lett. 
2012 , 14 , 429 10.1021/ol202683k .22196165 
Dong Y. ; Yun H. ; Park C. S. ; Lee W. K. ; Ha H.-J. 
Acta Crystallogr., Sect.
C: Cryst. Struct. Commun. 
2003 , 59 , 659 10.1107/s0108270103022698 .
a Baldwin J.
E. 
J. Chem. Soc., Chem. Commun. 
1976 , 734 10.1039/c39760000734 . b Overhand M. ; Hecht S. M. 
J. Org. Chem. 
1994 , 59 , 4721 10.1021/jo00096a007 . c Gilmore K. ; Alabugin I. V. 
Chem. Rev. 
2011 , 111 , 6513 10.1021/cr200164y .21861478 
a Fustero S. ; Rodríguez E. ; Herrera L. ; Asensio A. ; Maestro M. A. ; Barrio P. 
Org. Lett. 
2011 , 13 , 6564 10.1021/ol2028948 .22111789  b Gurjar A. ; Poonia P. ; Sinha P. ; Bansal R. K. 
Tetrahedron Lett. 
2014 , 55 , 2504 10.1016/j.tetlet.2014.03.013 . c Fan M.-J. ; Li G.-Q. ; Liang Y.-M. 
Tetrahedron 
2006 , 62 , 6782 10.1016/j.tet.2006.04.100 . d Vedejs E. ; Gingras M. 
J. Am. Chem. Soc. 
1994 , 116 , 579 10.1021/ja00081a019 .
a Lautens M. ; Fillion E. 
J. Org. Chem. 
1997 , 62 , 4418 10.1021/jo9701593 .11671769  b Kozmin S. A. ; Rawal V. H. 
J. Am. Chem. Soc. 
1997 , 119 , 7165 10.1021/ja971272d . c Wei K. ; Gao H.-T. ; Li W.-D. Z. 
J. Org. Chem. 
2004 , 69 , 5763 10.1021/jo049210a .15307754  d Reddy B. V.
S. ; Yadav N. N. ; Srivastava N. ; Yadav J. S. ; Sridhar B. 
Helv. Chim. Acta 
2012 , 95 , 76 10.1002/hlca.201100250 .

